Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Cannabis

DEA's Cannabis Rescheduling Hearing Set To Begin In January 2025 As Controversy Mounts

DEA's cannabis rescheduling hearing begins January 21, 2025, as the industry raises concerns over process transparency and political influence.

Benzinga

Is Tilray Stock a Buy on Positive Cannabis Data?

Tilray reported a positive update for its chemo-related drug.

Barchart

Cannabotech’s CBD drops will give you the kind of beauty sleep you dream of

One reviewer called the drops ”a game-changer and life saver in equal measures”

Evening Standard

From analysis to the latest developments in health,
read the most diverse news in one place.

Nottinghamshire Police find over 200 cannabis plants after stopping van

'We certainly got more than we bargained for,' said police

Nottingham Post

Uber Eats' cannabis delivery partnership with Leafly is mostly smoke and mirrors

Before 2018, cannabis was illegal in Canada. Now, as of mid-October, Uber Eats can deliver it in Toronto as the result of a partnership with Leafly, an online marketplace for licensed cannabis retailers. This is the first time Uber will deliver cannabis anywhere in the world.

The Conversation

This Is How It's Done: Why Is Canopy's US Consolidation Plan Blueprint For Other Canadian Cannabis LPs

Canadian cannabis giant Canopy Growth Corporation (NASDAQ: CGC) (TSX:WEED) announced its intention to consolidate in the US via a new holding company dubbed Canopy

Benzinga

Humble & Fume Reports YoY Drop In Q4 Revenue, Expects Further Topline Growth In 2023

Humble & Fume Inc. (CSE: HMBL) (OTCQX: HUMBF), a distributor of cannabis and cannabis accessories, reported its financial results for the fiscal 2022 fourth quarter and year ended June 30, 2022.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Smoking Pot Makes You 55% Less Likely To Develop This Deadly Cancer

Marijuana users have 55% fewer chances of developing, one of the most common malignancies worldwide - hepatocellular carcinoma (HCC), according to a study

Benzinga

The Value Cannabis Accountants Provide for the Pre-Revenue Process

Andrew Hunzicker, CEO of DOPE CFO When we think of accounting professionals within the Cannabis niche, often we’re only thinking about how to keep clients compliant once their business is already operational. But what does it look like to help a client who has not yet opened for business?

Benzinga

Cannabis Movers & Shakers: Fire & Flower, POSaBIT, Zoned Properties, Urban Aroma

Fire & Flower Names Alimentation Couche-Tard’s Exec To Serve As CEO

Benzinga

EXCLUSIVE: Cannabis Business Awards Returns To Honor Cannabis Industry, Adds Psychedelics And Sports Awards

The Cannabis Business Awards are turning 10 years old and returning this June 2nd to the breathtaking Sacred Space in Wynwood, Miami, Florida, to celebrate it.

Benzinga

Cannabis And Cancer Pain: Israeli Study Shows Medical Marijuana Effective, Nearly 50% Of Patients Stop Traditional Pain Meds

Medical marijuana can help those suffering from cancer-associated pain, as per a new Technion study published on Friday in Frontiers in Pain Research.

Benzinga

DEA-Endorsed Cannabis Grower Makes History As First 'Plant-Touching' Firm On NASDAQ, Shares Soared

Bright Green Corporation (NASDAQ: BGXX), one of the very few companies selected by the US government to grow, manufacture and sell cannabis and cannabis-related research products, went public on the NASDAQ Tuesday, becoming the first U.S. plant-touching company to list on a major U.S.

Benzinga

Cannabis In Cancer Treatment: Feds To Fund New Research In These Areas Of Interest

In cancer patients, cannabinoids have primarily been used as a part of palliative care to help alleviate pain, reduce inflammation, relieve nausea and stimulate appetite.

Benzinga

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Cannabotech To Manufacture Oncology Products Via Partnership With California Medical Cannabis Producer

Cannabotech has announced a new strategic partnership with the Californian corporation go NXT LVL. This agreement will allow Cannabotech's integrative oncology products to be developed and manufactured at go NXT LVL's facilities in accordance with the California Medical Cannabis Regulations.

Benzinga

Here's Why OrganiGram Shares Are Rising

Shares of many cannabis stocks, including OrganiGram Holdings Inc (NASDAQ: OGI), are trading higher following an afternoon report Thursday U.S. House Rules Committee has scheduled a Monday-afternoon meeting to prep federal marijuana legalization bill for floor action.

Benzinga

Here's Why Aurora Cannabis, Canopy Growth, Cronos Group, Sundial Growers And Tilray Shares Are Popping Off

Shares of several cannabis stocks, including Aurora Cannabis Inc (NASDAQ: ACB), Canopy Growth Corp (NASDAQ: CGC), Cronos Group Inc (NASDAQ:

Zenger

Mixing Medical Mushrooms And Cannabis For Cancer Care

Cannabotech’s idea is not to replace existing cancer treatments but to enable a patient to have fewer treatments.

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Cannabis & Mushrooms Versus Colon Cancer: Cannabotech's Product Kills Over 90% Of Cancerous Colon Cells

An Israeli biotech company that develops medical products based on cannabis and fungal extracts, Cannabotech reported Tuesday cell model study results showing that its "Integrative-Colon" products killed over 90% of colon cancer cells. The Integrative-Colon products are based on a combination of several cannabinoids from the cannabis plan

People

Pablo Zuanic

101 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Nottinghamshire Police

Canopy Growth Corporation

45 stories

Sam

43 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.